Clinical and molecular profiles of radioiodine refractory differentiated thyroid cancer

被引：1
|
作者：
Lin, Y. [1 ]
Zhang, X. [1 ]
He, H. [2 ]
Huang, L. [3 ]
Ding, S. [4 ]
Kai, Z. [4 ]
Lin, R. [5 ]
Luo, P. [6 ]
机构：
[1] Peking Unin Med Coll Hosp, Nucl Med, Beijing, Peoples R China
[2] Zhejiang Shaoxing Topgen Biomed Technol Co Ltd, Tech Dept, Shanghai, Peoples R China
[3] Zhejiang Shaoxing Topgen Biomed Technol Co Ltd, Med Dept, Shanghai, Peoples R China
[4] Zhejiang Shaoxing Topgen Biomed Technol Co Ltd, Bioinformat Dept, Shanghai, Peoples R China
[5] Zhejiang Topgen Biomed Technol Co Ltd, Qual Dept, Huzhou, Peoples R China
[6] Zhejiang Shaoxing Topgen Biomed Technol Co Ltd, Mkt Ctr, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1657P
引用
收藏
页码：S1300 / S1300
页数：1
相关论文
共 50 条
  • [1] Clinical guidance for radioiodine refractory differentiated thyroid cancer
    Gild, Matti L.
    Topliss, Duncan J.
    Learoyd, Diana
    Parnis, Francis
    Tie, Jeanne
    Hughes, Brett
    Walsh, John P.
    McLeod, Donald S. A.
    Clifton-Bligh, Roderick J.
    Robinson, Bruce G.
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 88 (04) : 529 - 537
  • [2] Radioiodine refractory differentiated thyroid cancer
    Boudina, Maria
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 : 65 - 68
  • [3] Radioiodine refractory differentiated thyroid cancer
    Jin, Yuchen
    Van Nostrand, Douglas
    Cheng, Lingxiao
    Liu, Min
    Chen, Libo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 111 - 120
  • [4] Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
    Ovcaricek, Petra Petranovic
    Campenni, Alfredo
    de Keizer, Bart
    Deandreis, Desiree
    Kreissl, Michael C.
    Vrachimis, Alexis
    Tuncel, Murat
    Giovanella, Luca
    [J]. CANCERS, 2023, 15 (17)
  • [5] Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
    Gomes-Lima, Cristiane J.
    Shobab, Leila
    Wu, Di
    Ylli, Dorina
    Bikas, Athanasios
    McCoy, Matthew
    Feldman, Rebecca
    Lee, Wen
    Rao, Sarika N.
    Jensen, Kirk
    Vasko, Vasily
    Castro, Luiz Claudio
    Jonklaas, Jacqueline
    Wartofsky, Leonard
    Burman, Kenneth D.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [6] Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
    Shen, Huize
    Zhu, Rui
    Liu, Yanyang
    Hong, Yangjian
    Ge, Jiaming
    Xuan, Jie
    Niu, Wenyuan
    Yu, Xuefei
    Qin, Jiang-Jiang
    Li, Qinglin
    [J]. DRUG RESISTANCE UPDATES, 2024, 72
  • [7] Treatment strategy by radioiodine refractory differentiated thyroid cancer
    Mantsopoulos, Konstantinos
    Mueller, Sarina K.
    Pavel, Marianne
    Kuwert, Torsten
    Meidenbauer, Norbert
    Fietkau, Rainer
    Sievert, Matti
    Iro, Heinrich
    [J]. LARYNGO-RHINO-OTOLOGIE, 2022, 101 (04) : 298 - 303
  • [8] Advanced Radioiodine-refractory differentiated Thyroid Cancer
    Spitzweg, Christine
    Auernhammer, Christoph J.
    Geisler, Julia
    Boeck, Stefan
    Heinemann, Volker
    Bartenstein, Peter
    Goeke, Burkhard
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (03) : 168 - 171
  • [9] Cabozantinib for radioiodine-refractory differentiated thyroid cancer
    Chiapponi, Costanza
    Hartmann, Milan J. M.
    Hescheler, Daniel A.
    Alakus, Hakan
    [J]. ONKOLOGE, 2021, 27 (12): : 1241 - 1242
  • [10] Radioiodine refractory differentiated thyroid cancer classifications and evolution
    Wu, Di
    Lima, Cristiane Jeyce Gomes
    Turner, Deniek
    Burman, Kenneth
    Van Nostrand, Douglas
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345